BioSyent Pharma Secures Two Long-Term Hospital Supply Contracts for Cathejell(TM) Jelly 2%-Shipments Commence
June 19, 2012 20:02 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwire - June 19, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today announced that its subsidiary BioSyent Pharma Inc. has secured two long-term hospital...
BioSyent Releases First Quarter Results-Sales Increase 89%, Net Income Sets All-Time Quarterly Record
May 22, 2012 17:30 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwire - May 22, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its First Quarter (Q1) 2012 financial results.
...
BioSyent Pharma Launches Cathejell(TM) Jelly 2%; Shipments to Commence May 2012
May 09, 2012 16:43 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwire - May 9, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has launched Cathejell™...
BioSyent Releases Fiscal 2011 and Fourth Quarter Financial Results-Strong Growth Continues
March 29, 2012 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwire - March 29, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Fiscal 2011 and Fourth Quarter (Q4) 2011 financial results.
...
BioSyent Named to the TSX Venture Top 50(R) Ranking
February 15, 2012 18:28 ET
|
BioSyent Inc.
MISSISSAUGA, ONTARIO--(Marketwire - Feb. 15, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) announced today that it has been named as one of the 2012 TSX Venture Top 50 companies.
...
BioSyent Announces Appointment of New Director
December 15, 2011 17:48 ET
|
BioSyent Inc.
MISSISSAUGA, ONTARIO--(Marketwire - Dec. 15, 2011) - The Board of Directors of BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce the appointment of Paul R. Montador to...
BioSyent Releases Third Quarter 2011 Financial Results-Pharma Sales More Than Triple; YTD Sales Growth 73%
November 15, 2011 16:00 ET
|
BioSyent Inc.
MISSISSAUGA, ONTARIO--(Marketwire - Nov. 15, 2011) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Third Quarter (Q3) 2011 financial results.
Total...
BioSyent Releases Second Quarter 2011 Financial Results-Pharma Sales Triple; Total Sales Growth 123%
August 24, 2011 16:00 ET
|
BioSyent Inc.
MISSISSAUGA, ONTARIO--(Marketwire - Aug. 24, 2011) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Second Quarter (Q2) 2011 financial results.
Total...
BioSyent Pharma Receives Health Canada Approval for New In-Licensed Topical Anesthetic
July 28, 2011 16:48 ET
|
BioSyent Inc.
MISSISSAUGA, ONTARIO--(Marketwire - July 28, 2011) - BioSyent Inc. (TSX VENTURE:RX) ("BioSyent") announces that its subsidiary BioSyent Pharma Inc. together with its manufacturing partner...
BioSyent Releases First Quarter 2011 Financial Results-Strong Growth Continues, Sales Increase 54%
June 27, 2011 16:08 ET
|
BioSyent Inc.
MISSISSAUGA, ONTARIO--(Marketwire - June 27, 2011) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its First Quarter (Q1) 2011 financial results. These results have been...